The Tyrosine Phosphatase hPTPRβ Controls the Early Signals and Dopaminergic Cells Viability via the P2X7 Receptor
暂无分享,去创建一个
J. Zugaza | Hadriano M. Lacerda | Alazne Arrazola Sastre | Miriam Luque Montoro | Francisco Llavero Bernal
[1] F. Markwardt. Human P2X7 receptors - properties of single ATP-gated ion channels. , 2020, Biochemical pharmacology.
[2] P. Agostinho,et al. Purinergic signaling orchestrating neuron-glia communication. , 2020, Pharmacological research.
[3] A. Lucia,et al. Small GTPases of the Ras and Rho Families Switch on/off Signaling Pathways in Neurodegenerative Diseases , 2020, International journal of molecular sciences.
[4] P. Illés. P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases , 2020, International journal of molecular sciences.
[5] H. Ulrich,et al. The P2X7 Receptor: Central Hub of Brain Diseases , 2020, Frontiers in Molecular Neuroscience.
[6] Antonio G. García,et al. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases , 2020, Medicinal research reviews.
[7] H. Ulrich,et al. P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson’s Disease , 2019, Front. Cell. Neurosci..
[8] S. Rohrbach,et al. Role of PI3K/Akt and MEK/ERK Signalling in cAMP/Epac-Mediated Endothelial Barrier Stabilisation , 2019, Front. Physiol..
[9] G. Bormans,et al. Increased P2X7 Receptor Binding Is Associated With Neuroinflammation in Acute but Not Chronic Rodent Models for Parkinson’s Disease , 2019, Front. Neurosci..
[10] Bing Lang,et al. The Ras Superfamily of Small GTPases in Non-neoplastic Cerebral Diseases , 2019, Front. Mol. Neurosci..
[11] A. Lucia,et al. Epidermal growth factor receptor controls glycogen phosphorylase in T cells through small GTPases of the RAS family , 2019, The Journal of Biological Chemistry.
[12] Mohammad Reza Ahmadian,et al. Structural fingerprints, interactions, and signaling networks of RAS family proteins beyond RAS isoforms , 2018, Critical reviews in biochemistry and molecular biology.
[13] Xiao-Guang Luo,et al. Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease , 2016, Molecular medicine reports.
[14] J. Zugaza,et al. Lck/PLCγ control migration and proliferation of interleukin (IL)-2-stimulated T cells via the Rac1 GTPase/glycogen phosphorylase pathway. , 2016, Cellular signalling.
[15] G. Zheng,et al. Expression and function of P2 receptors in hematopoietic stem and progenitor cells. , 2015, Stem cell investigation.
[16] J. Zugaza,et al. Guanine Nucleotide Exchange Factor αPIX Leads to Activation of the Rac 1 GTPase/Glycogen Phosphorylase Pathway in Interleukin (IL)-2-stimulated T Cells , 2015, The Journal of Biological Chemistry.
[17] M. Herrero,et al. Dyskinesia in Parkinson's disease: mechanisms and current non‐pharmacological interventions , 2014, Journal of neurochemistry.
[18] R. Cunha,et al. The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis , 2014, Neuropharmacology.
[19] T. Deuel. Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway. , 2013, Biochimica et biophysica acta.
[20] Yuxiang Wu,et al. P2X3, but not P2X1, receptors mediate ATP-activated current in neurons innervating tooth-pulp , 2013, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[21] F. Di Virgilio,et al. The P2X7 receptor is a key modulator of aerobic glycolysis , 2012, Cell Death and Disease.
[22] J. Zugaza,et al. Rac1 Protein Regulates Glycogen Phosphorylase Activation and Controls Interleukin (IL)-2-dependent T Cell Proliferation* , 2012, The Journal of Biological Chemistry.
[23] W. Becker,et al. Extracellular ATP activates NFAT-dependent gene expression in neuronal PC12 cells via P2X receptors , 2011, BMC Neuroscience.
[24] J. Stone. Regulation and Function of the RasGRP Family of Ras Activators in Blood Cells. , 2011, Genes & cancer.
[25] Yiming Zhu,et al. Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions , 2011, Immunologic research.
[26] K. Tufekci,et al. The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease , 2011, Parkinson's disease.
[27] G. Burnstock,et al. Microglia: proliferation and activation driven by the P2X7 receptor. , 2010, The international journal of biochemistry & cell biology.
[28] L. Minichiello. TrkB signalling pathways in LTP and learning , 2009, Nature Reviews Neuroscience.
[29] R. Palmer,et al. Anaplastic lymphoma kinase: signalling in development and disease , 2009, The Biochemical journal.
[30] Jian Feng,et al. Parkin Protects Dopaminergic Neurons against Microtubule-depolymerizing Toxins by Attenuating Microtubule-associated Protein Kinase Activation* , 2009, Journal of Biological Chemistry.
[31] B. Liu,et al. The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery , 2008, Fundamental & clinical pharmacology.
[32] C. Chu,et al. Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress , 2008, Autophagy.
[33] Y. Kong,et al. Extracellular ATP Mediates Necrotic Cell Swelling in SN4741 Dopaminergic Neurons through P2X7 Receptors* , 2007, Journal of Biological Chemistry.
[34] T. Mathivet,et al. In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)? , 2007, Cellular signalling.
[35] Wei Zhang,et al. Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation. , 2007, The Journal of biological chemistry.
[36] D. Donnelly-roberts,et al. Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states , 2007, British journal of pharmacology.
[37] R. Heumann,et al. Enhancement of dopaminergic properties and protection mediated by neuronal activation of Ras in mouse ventral mesencephalic neurones , 2007, The European journal of neuroscience.
[38] T. Hagg,et al. Protein tyrosine phosphatase inhibition reduces degeneration of dopaminergic substantia nigra neurons and projections in 6‐OHDA treated adult rats , 2007, The European journal of neuroscience.
[39] Joffrey L. Degoutin,et al. ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation , 2007, FEBS letters.
[40] R. Schnellmann,et al. A Death-Promoting Role for Extracellular Signal-Regulated Kinase , 2006, Journal of Pharmacology and Experimental Therapeutics.
[41] K. Wada,et al. Parkin potentiates ATP‐induced currents due to activation of P2X receptors in PC12 cells , 2006, Journal of cellular physiology.
[42] I. Chessell,et al. P2X7 receptors on microglial cells mediate injury to cortical neurons in vitro , 2006, Glia.
[43] C. Créminon,et al. Activation and Inhibition of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase by Monoclonal Antibodies and Absence of Agonist Activity of Pleiotrophin* , 2005, Journal of Biological Chemistry.
[44] A. Sidhu,et al. D1 Dopamine Receptor Mediates Dopamine-induced Cytotoxicity via the ERK Signal Cascade* , 2004, Journal of Biological Chemistry.
[45] D. Burstein,et al. Ectopic expression of murine diphosphoinositol polyphosphate phosphohydrolase 1 attenuates signaling through the ERK1/2 pathway. , 2004, Cellular signalling.
[46] Hitoshi Sakuraba,et al. ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth , 2004, Journal of Cell Science.
[47] J. Kanellopoulos,et al. The Pro-451 to Leu Polymorphism within the C-terminal Tail of P2X7 Receptor Impairs Cell Death but Not Phospholipase D Activation in Murine Thymocytes* , 2004, Journal of Biological Chemistry.
[48] T. Oury,et al. Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases. , 2002, The American journal of pathology.
[49] Kazuhide Inoue. Microglial activation by purines and pyrimidines , 2002, Glia.
[50] N. Rothwell,et al. Extracellular ATP and P2X7 receptors in neurodegeneration. , 2002, European journal of pharmacology.
[51] P. Ping,et al. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. , 2002, Circulation research.
[52] C. Coscia,et al. Diversity of G Protein-Coupled Receptor Signaling Pathways to ERK/MAP Kinase , 2002, Neurosignals.
[53] R. North. Molecular physiology of P2X receptors. , 2002, Physiological reviews.
[54] Miran Kim,et al. Proteomic and functional evidence for a P2X7 receptor signalling complex , 2001, The EMBO journal.
[55] B. Souttou,et al. Activation of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase Induces Neuronal Differentiation through the Mitogen-activated Protein Kinase Pathway* , 2001, The Journal of Biological Chemistry.
[56] K. Adamsky,et al. Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase β (RPTPβ) to tenascin C , 2001, Oncogene.
[57] D. Ferrari,et al. P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death , 1999, FEBS letters.
[58] T. Joh,et al. Neuroprotection and Neuronal Differentiation Studies Using Substantia Nigra Dopaminergic Cells Derived from Transgenic Mouse Embryos , 1999, The Journal of Neuroscience.
[59] E. Martegani,et al. The Ras Guanine nucleotide Exchange Factor CDC25Mm is present at the synaptic junction. , 1997, Experimental cell research.
[60] Anirvan Ghosh,et al. Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF , 1995, Nature.
[61] Frank McCormick,et al. The GTPase superfamily: conserved structure and molecular mechanism , 1991, Nature.
[62] Peter P. Lee,et al. Purinergic Signaling Within the Tumor Microenvironment. , 2021, Advances in experimental medicine and biology.
[63] Kozo Kaibuchi,et al. Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. , 2004, Microvascular research.
[64] K. Adamsky,et al. Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase beta (RPTPbeta) to tenascin C. , 2001, Oncogene.